About GRAIL, INC.
GRAIL is a company focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning to screen for deadly cancer types before symptoms appear. The company developed the Galleri® test, a multi-cancer early detection (MCED) test.
Multi-cancer early detection (MCED) testingNext-generation sequencingPopulation-scale clinical studiesMachine learning and automation for cancer screening
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GRAIL, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.